US Gastroenterologists Project Swift Uptake of Madrigal Phar

US Gastroenterologists Project Swift Uptake of Madrigal Pharmaceuticals' Rezdiffra (resmetirom) for the Treatment of Metabolic Dysfunction-Associated…

EXTON, PA, April 05, 2024 (GLOBE NEWSWIRE) -- As the first treatment to gain FDA approval for metabolic dysfunction-associated steatohepatitis (MASH),…

Related Keywords

, Madrigal Pharmaceutical Rezdiffra , Spherix Global Insights , News , Ggregator , Reaking News , Uration , Media ,